The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes

Background. It has been well accepted that insulin therapy is the ideal treatment for newly diagnosed diabetic patients. However, there was no study about assessment of the initial insulin dosage in new onset Chinese patients with type 2 diabetes. Research Design and Methods. 65 newly diagnosed patients with type 2 diabetes (39 males/26 females; HbA1c ≥ 11.80 ± 0.22%) were investigated. All patients had random hyperglycaemia (at 21.8 ± 3.9 mmol/L) on the first day of admission and received insulin infusion intravenously (5 U/per hour). When the blood glucose level dropped to around 10 mmol/L, patients were then transferred to continuous subcutaneous insulin infusion (CSII). The reduction of blood glucose levels in response to per unit of insulin (RBG/RI) was recorded. The target glucose level was achieved in about 3 days. The total daily insulin dose (TDD) and basal insulin dose (TBD) were calculated. Results. TDD was 45.97 ± 1.28 units and TBD was 19.00 ± 0.54 units. TBD was about 40% of the total daily insulin requirement. There was a negative correlation between the ratio of RBG/RI and TDD. Conclusions. TDD was correlated with blood glucose reduction in response to intravenous insulin infusion in Chinese new onset patients with type 2 diabetes.

[1]  Wenying Yang,et al.  Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. , 2014, The lancet. Diabetes & endocrinology.

[2]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[3]  Y. Mu,et al.  Insulin pump therapy guidelines for China (July 2010) , 2012, Journal of diabetes.

[4]  J. Weng,et al.  Short-Term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and β-Cell Function in Subjects With Long-Term Remission , 2011, Diabetes Care.

[5]  I. Shimomura,et al.  Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump , 2011, Diabetes Care.

[6]  L. Jovanovič,et al.  Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  John Walsh,et al.  Guidelines for Insulin Dosing in Continuous Subcutaneous Insulin Infusion Using New Formulas from a Retrospective Study of Individuals with Optimal Glucose Levels , 2010, Journal of diabetes science and technology.

[8]  An‐Tsz Hsieh,et al.  Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide , 2010, Archives of pharmacal research.

[9]  Wenying Yang,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[10]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[11]  W. Jia,et al.  [Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices]. , 2009, Zhonghua yi xue za zhi.

[12]  H. Tian,et al.  Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial , 2008, The Lancet.

[13]  M. Prentki,et al.  Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.

[14]  I. Harman-boehm,et al.  Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[15]  Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  A. Kitabchi,et al.  Diabetic ketoacidosis: low-dose insulin therapy by various routes. , 1977, The New England journal of medicine.